The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 6, 2026 | Kunkel Lori Anne | Director | Sell(S) | 4K | $49.98 | $205K |
| Jul 6, 2026 | Kunkel Lori Anne | Director | Sell(S) | 6K | $50.84 | $299K |
| Jun 22, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 25K | $45.38 | $1.1M |
| Jun 22, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 1K | $45.00 | $66K |
| Jun 22, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 787K | $45.38 | $35.7M |
| Jun 22, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 47K | $45.00 | $2.1M |
| Jun 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 6K | $2.48 | $15K |
| Jun 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell(S) | 1K | $42.79 | $59K |
| Jun 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell(S) | 3K | $43.86 | $149K |
| Jun 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell(S) | 1K | $44.75 | $55K |
| Jun 17, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 6K | — | $0 |
| Jun 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | $2.48 | $12K |
| Jun 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 1K | $42.83 | $54K |
| Jun 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 3K | $43.87 | $114K |
| Jun 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 1K | $44.74 | $51K |
| Jun 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | $0 |
| Jun 15, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 9K | $45.02 | $409K |
| Jun 15, 2026 | Orbimed Advisors LLC | 10% Owner | Sell(S) | 272K | $45.02 | $12.3M |
| Jun 5, 2026 | Kunkel Lori Anne | Director | Sell(S) | 8K | $34.28 | $267K |
| Jun 5, 2026 | Kunkel Lori Anne | Director | Sell(S) | 2K | $35.36 | $66K |
| Jun 5, 2026 | Kunkel Lori Anne | Director | Sell(S) | 354 | $35.82 | $13K |
| May 18, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | $2.48 | $12K |
| May 18, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 3K | $39.53 | $137K |
| May 18, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 1K | $40.25 | $52K |
| May 18, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 223 | $41.21 | $9K |
| May 18, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | $0 |
| Apr 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | $2.48 | $12K |
| Apr 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 140 | $45.81 | $6K |
| Apr 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 2K | $47.39 | $115K |
| Apr 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 2K | $48.06 | $117K |
| Apr 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | $0 |
| Mar 25, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 40K | $2.48 | $99K |
| Mar 25, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 40K | $35.10 | $1.4M |
| Mar 25, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 40K | — | $0 |
| Mar 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 5K | $27.76 | $139K |
| Mar 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | $2.48 | $12K |
| Mar 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 5K | — | $0 |
| Mar 10, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 10K | $30.19 | $306K |
| Mar 10, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | $2.48 | $25K |
| Mar 10, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 10K | — | $0 |
| Mar 9, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 30K | $30.02 | $897K |
| Mar 9, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 30K | $2.48 | $74K |
| Mar 9, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 30K | — | $0 |
| Mar 6, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell(S) | 10K | $29.58 | $296K |
| Feb 17, 2026 | Heyman Richard A. | Director | Sell(S) | 1K | $26.18 | $32K |
| Feb 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Sell(S) | 45K | $26.17 | $1.2M |
| Feb 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 45K | $2.48 | $112K |
| Feb 17, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Option exercise(M) | 45K | — | $0 |
| Feb 12, 2026 | Garland J. Scott | Director | Grant(A) | 1K | — | $0 |
| Feb 12, 2026 | Kunkel Lori Anne | Director | Grant(A) | 17K | — | $0 |
| Feb 12, 2026 | Gupta Rishi | Director | Grant(A) | 2K | — | $0 |
| Feb 12, 2026 | Gupta Rishi | Director | Grant(A) | 34K | — | $0 |
| Feb 12, 2026 | Heyman Richard A. | Director | Grant(A) | 19K | — | $0 |
| Feb 12, 2026 | Bauer Jake | Director | Grant(A) | 17K | — | $0 |
| Feb 12, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Grant(A) | 25K | — | $0 |
| Feb 12, 2026 | Collins Helen Louise | CHIEF MEDICAL OFFICER | Grant(A) | 150K | — | $0 |
| Feb 12, 2026 | Ballal Rahul D. | Director | Grant(A) | 17K | — | $0 |
| Feb 12, 2026 | Derynck Mika K | Director | Grant(A) | 17K | — | $0 |
| Feb 12, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Grant(A) | 25K | — | $0 |
| Feb 12, 2026 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Grant(A) | 150K | — | $0 |
| Feb 12, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Grant(A) | 19K | — | $0 |
| Feb 12, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Grant(A) | 113K | — | $0 |
| Feb 12, 2026 | Patel Anish | CHIEF OPERATING OFFICER | Grant(A) | 20K | — | $0 |
| Feb 12, 2026 | Patel Anish | CHIEF OPERATING OFFICER | Grant(A) | 120K | — | $0 |
| Feb 6, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 5K | $29.04 | $145K |
| Jan 20, 2026 | Heyman Richard A. | Director | Sell(S) | 512 | $26.46 | $14K |
| Jan 20, 2026 | Heyman Richard A. | Director | Sell(S) | 718 | $26.96 | $19K |
| Jan 20, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 15K | $26.90 | $390K |
| Jan 20, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 5K | $26.37 | $145K |
| Jan 9, 2026 | Heyman Richard A. | Director | Sell(S) | 4K | $25.00 | $107K |
| Jan 9, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 41K | $24.90 | $1.0M |
| Jan 9, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 50K | $29.13 | $1.5M |
| Jan 9, 2026 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 243 | $28.50 | $7K |
| Jan 9, 2026 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 48K | $27.98 | $1.3M |
| Jan 8, 2026 | Heyman Richard A. | Director | Sell(S) | 8K | $25.04 | $201K |
| Jan 8, 2026 | Heyman Richard A. | Director | Sell(S) | 2K | $25.00 | $41K |
| Jan 8, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 8K | $20.13 | $151K |
| Jan 8, 2026 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 34K | $24.92 | $842K |
| Jan 7, 2026 | Garland J. Scott | Director | Grant(A) | 59K | — | $0 |
| Dec 22, 2025 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 13K | $2.48 | $32K |
| Dec 22, 2025 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 13K | — | $0 |
| Dec 19, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 5K | $16.84 | $84K |
| Dec 17, 2025 | Kunkel Lori Anne | Director | Option exercise(M) | 16K | $1.12 | $18K |
| Dec 17, 2025 | Kunkel Lori Anne | Director | Option exercise(M) | 16K | — | $0 |
| Dec 11, 2025 | Fair Richard A. | PRESIDENT AND CEO, Director | Grant(A) | 875K | — | $0 |
| Dec 8, 2025 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 5K | $20.76 | $103K |
| Dec 8, 2025 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 2K | $21.78 | $37K |
| Nov 19, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 12K | $22.30 | $268K |
| Nov 19, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 492 | $23.09 | $11K |
| Nov 17, 2025 | Kintz Samuel | PRESIDENT AND CEO, Director | Sell(S) | 13K | $21.82 | $273K |
| Nov 7, 2025 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 6K | $17.35 | $105K |
| Nov 7, 2025 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 613 | $17.94 | $11K |
| Oct 20, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 13K | $22.08 | $276K |
| Oct 17, 2025 | Kintz Samuel | PRESIDENT AND CEO, Director | Sell(S) | 13K | $21.33 | $267K |
| Oct 7, 2025 | Patel Anish | CHIEF OPERATING OFFICER | Sell(S) | 7K | $20.10 | $134K |
| Sep 29, 2025 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Sell(S) | 3K | $20.40 | $66K |
| Sep 29, 2025 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | $2.48 | $8K |
| Sep 29, 2025 | Hohl Benjamin | CHIEF FINANCIAL OFFICER | Option exercise(M) | 3K | — | $0 |
| Sep 26, 2025 | Lyssikatos Joseph P | CHIEF SCIENTIFIC OFFICER | Sell(S) | 4K | $20.25 | $81K |
| Sep 26, 2025 | Kintz Samuel | PRESIDENT AND CEO, Director | Sell(S) | 4K | $20.06 | $74K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).